CommercialCoverageMedium impact
State and School Employees' Health Insurance Plan - Spinraza (nusinersen)
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Pediatrics, General Practice·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a new comprehensive medical policy for Spinraza (nusinersen) coverage under the State and School Employees' Health Insurance Plan. The policy establishes detailed initial and continuation criteria for coverage of this spinal muscular atrophy treatment, requiring specific genetic testing documentation, baseline motor assessments, and ongoing clinical response measurements.
Action Required
Immediately: Billing team must implement prior authorization requirements for HCPCS code J2326 (nusinersen injection) under State and School Employees' Health Insurance Plan. Providers treating SMA patients must document all required criteria including genetic testing results, baseline motor assessments (HINE-2, HFMSE, ULM, or CHOP INTEND), symptom onset timing, and ensure specialist consultation before billing. For continuation claims, document clinical response within previous 30 days using specified assessment tools. Claims will be denied without proper documentation of medical necessity criteria.